CODX - Company ID 0001692415
The table below shows Co-Diagnostics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $622.49K | $3.92M | $6.81M | $34.22M | $97.89M | $74.55M |
| Cost of revenue | $222.38K | $999.12K | $4.18M | $5.48M | $11.57M | $16.59M |
| Gross profit | $400.11K | $2.92M | $2.63M | $28.74M | $86.31M | $57.96M |
| R&D | $19.14M | $20.98M | $22.96M | $17.44M | $14.96M | $3.19M |
Co-Diagnostics, Inc. reported annual revenue of $622.49K for fiscal year 2025. That is down 84.1% from $3.92M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $7.66K (FY 2017) to $622.49K. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $9.06M |
| $16.16M |
| $14.28M |
| $14.26M |
| $11.55M |
| $8.28M |
| Operating income | -$50.17M | -$40.08M | -$42.71M | -$26.98M | $46.06M | $41.69M |
| Income tax | -$1.62M | $57.37K | -$2.78M | -$4.61M | $8.98M | $90.54K |
| Net income | -$46.90M | -$37.64M | -$35.33M | -$14.24M | $36.66M | $42.48M |
| EPS (diluted) | -$35.25 | -$37.22 | -$1.20 | -$0.45 | $1.23 | $1.52 |